Associated Papers
ATR&RNASEL germline variants: novel findings in a case of familial cancer.
Biswas S et al.
Molecular Genetics and Genomics : Mgg, 2025
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.
Lee D et al.
Science (new York, N.y.), 2023
Activated leukocyte cell adhesion molecule/cluster of differentiation 166 rs10933819 (G>A) variant is associated with familial intracranial aneurysms.
Aitkulova A et al.
Biomedical Reports, 2022
Sequence and Structure-Based Analyses of Human Ankyrin Repeats.
Chakrabarty B et al.
Molecules (basel, Switzerland), 2022
Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer.
Niwinska A et al.
Diagnostics (basel, Switzerland), 2020
Precision Health Resource of Control iPSC Lines for Versatile Multilineage Differentiation.
Hildebrandt MR et al.
Stem Cell Reports, 2019
Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes.
Karyadi DM et al.
Oncotarget, 2017
Prognostic role of genetic biomarkers in clinical progression of prostate cancer.
Alvarez-Cubero MJ et al.
Experimental & Molecular Medicine, 2015
Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach.
Karageorgos I et al.
Human Genomics, 2015
Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL.
Datta A et al.
Biomed Research International, 2015
[Hereditary prostate cancer].
Heise M et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2014
Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a Hispanic population.
San Francisco IF et al.
Journal of Cellular and Molecular Medicine, 2014
Genetic analysis of the principal genes related to prostate cancer: a review.
Alvarez-Cubero MJ et al.
Urologic Oncology, 2013
The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients.
Alvarez-Cubero MJ et al.
Springerplus, 2013
Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer.
Alvarez-Cubero MJ et al.
Prostate Cancer and Prostatic Diseases, 2012
Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD et al.
The Prostate, 2011
[RNase L, a crucial mediator of innate immunity and other cell functions].
Bisbal C et al.
Medecine Sciences : M/s, 2008
SNPs associated with prostate cancer risk and prognosis.
Naylor SL
Frontiers in Bioscience : a Journal and Virtual Library, 2007
[Molecular basis of hereditary hemochromatosis].
Romanowski T et al.
Postepy Higieny I Medycyny Doswiadczalnej (online), 2006
RNASEL germline variants are associated with pancreatic cancer.
Bartsch DK et al.
International Journal of Cancer, 2005
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
Maier C et al.
British Journal of Cancer, 2005
Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Xiang Y et al.
Cancer Research, 2003
RNASEL mutations in hereditary prostate cancer.
Chen H et al.
Journal of Medical Genetics, 2003
Implications for RNase L in prostate cancer biology.
Silverman RH
Biochemistry, 2003
Analysis of the RNASEL gene in familial and sporadic prostate cancer.
Wang L et al.
American Journal of Human Genetics, 2002